We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$115M
AUM Growth
-$10.4M
Cap. Flow
-$9.14M
Cap. Flow %
-7.93%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
3
Closed

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 90.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$98.1M 85.2%
5,135,758
-277,142
-5% -$5.34M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$6.12M 5.31%
4,402,973
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$5.65M 4.9%
129,200
-42,000
-25% -$1.74M
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$5.28M 4.59%
151,800
-62,000
-29% -$2.05M

Similar funds

Meditor Group's Q2 2023 Portfolio in Review

As of Q2 2023, Meditor Group held 4 positions worth $115M, down 8.2% from $126M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $9.14M in Q2 2023, reducing 3 holdings. Its largest reduction was Exelixis, cutting an estimated $5.34M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 89% a quarter earlier.

  • Meditor Group's biggest Q2 2023 reduction was Exelixis, cutting an estimated $5.34M.
  • Meditor Group's ten largest holdings make up 100% of its $115M portfolio in Q2 2023.
  • Meditor Group opened 0 new positions and closed 0 in Q2 2023.
  • Meditor Group's portfolio value fell 8.2% quarter-over-quarter to $115M.

Based on Meditor Group's 13F filing for Q2 2023, filed 25 Jul 2023.